Pediatric Endocrinology in Office Practice - The Way Forward.

Indian J Pediatr

Department of Pediatric Endocrinology, Regency Center for Diabetes, Endocrinology & Research, Kanpur, Uttar Pradesh, India.

Published: June 2023

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12098-023-04618-5DOI Listing

Publication Analysis

Top Keywords

pediatric endocrinology
4
endocrinology office
4
office practice
4
practice forward
4
pediatric
1
office
1
practice
1
forward
1

Similar Publications

Global strategies for preventing type 2 diabetes: A public health perspective.

Indian J Med Res

November 2024

Department of Pediatrics, University of Alabama at Birmingham, Division of Pediatric Endocrinology and Diabetes, Alabama, 35233, United States.

View Article and Find Full Text PDF

Growth, Therapeutic Effectiveness, and Disparities in Pediatric Type 1 Diabetes: Lessons from Continuous Glucose Monitoring Use in Latin America.

J Pediatr Clin Pract

December 2024

Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

Heterodisomy in the locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3).

Front Endocrinol (Lausanne)

December 2024

Rare Disease Research Group, Molecular (Epi) Genetics Laboratory, Bioaraba Health Research Institute, Araba University Hospital, Vitoria-Gasteiz, Spain.

Objective: To identify the genetic cause underlying the methylation defect in a patient with clinical suspicion of PHP1B/iPPSD3.

Design: Imprinting is an epigenetic mechanism that allows the regulation of gene expression. The locus is one of the loci within the genome that is imprinted.

View Article and Find Full Text PDF

Fear of hypoglycemia and sleep in children with type 1 diabetes and their parents.

Front Endocrinol (Lausanne)

December 2024

Department of Pediatric Diabetes and Endocrinology, Clinique Pédiatrique, Centre Hospitalier, Luxembourg, Luxembourg.

Aims: To compare impact of pump treatment and continuous glucose monitoring (CGM) with predictive low glucose suspend (SmartGuard) or user initiated CGM (iscCGM) on sleep and hypoglycemia fear in children with type 1 Diabetes and parents.

Methods: Secondary analysis of data from 5 weeks pump treatment with iscCGM (A) or SmartGuard (B) open label, single center, randomized cross-over study was performed. At baseline and end of treatment arms, sleep and fear of hypoglycemia were evaluated using ActiGraph and questionnaires.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!